Conn's

Conn's syndrome, also known as primary aldosteronism or primary hyperaldosteronism, is a medical condition characterized by the excessive production of the hormone aldosterone by the adrenal glands. This overproduction leads to a range of symptoms and complications primarily affecting the cardiovascular and renal systems. The condition was first described by Jerome W. Conn in 1955, hence the name Conn's syndrome.

Etiology

Conn's syndrome can be caused by various factors that lead to the overproduction of aldosterone. The most common cause is an aldosterone-producing adenoma, a benign tumor of the adrenal gland. Other causes include adrenal hyperplasia, a condition where the adrenal glands are enlarged and produce too much aldosterone, and, rarely, adrenal carcinoma, a malignant adrenal tumor. In some cases, the cause of Conn's syndrome may be genetic.

Pathophysiology

Aldosterone is a hormone that plays a crucial role in regulating blood pressure and electrolyte balance by signaling the kidneys to retain sodium and excrete potassium. In Conn's syndrome, the excessive aldosterone leads to sodium and water retention, which increases blood volume and, consequently, blood pressure. The condition also causes the kidneys to excrete too much potassium, leading to hypokalemia (low potassium levels), which can cause muscle weakness, fatigue, and, in severe cases, cardiac arrhythmias.

Symptoms

The symptoms of Conn's syndrome can vary but often include high blood pressure (hypertension), muscle weakness, fatigue, headaches, and, in cases of severe hypokalemia, cardiac arrhythmias. Some individuals may also experience increased thirst and urination due to the body's attempt to balance the effects of excessive aldosterone.

Diagnosis

The diagnosis of Conn's syndrome involves a combination of clinical evaluation, biochemical tests, and imaging studies. Initial tests often include measuring aldosterone and renin levels in the blood, with a high aldosterone-to-renin ratio suggesting primary aldosteronism. Imaging studies, such as computed tomography (CT) scans or magnetic resonance imaging (MRI), are used to identify adrenal adenomas or hyperplasia. In some cases, adrenal vein sampling may be performed to confirm the diagnosis and determine the source of aldosterone overproduction.

Treatment

Treatment for Conn's syndrome depends on the underlying cause. In cases caused by an aldosterone-producing adenoma, surgical removal of the tumor is often recommended. For patients with adrenal hyperplasia or those who cannot undergo surgery, medical management with aldosterone antagonists, such as spironolactone or eplerenone, is typically prescribed. These medications help counteract the effects of excessive aldosterone. Additionally, managing hypertension and correcting hypokalemia are important aspects of treatment.

Prognosis

With appropriate treatment, the prognosis for individuals with Conn's syndrome is generally good. Surgical removal of an aldosterone-producing adenoma can often cure the condition, while medical management can effectively control symptoms and prevent complications in those with adrenal hyperplasia or those who are not surgical candidates.

Epidemiology

Conn's syndrome is a relatively rare condition, but it is an important cause of secondary hypertension. It is estimated to affect approximately 0.5-2% of individuals with hypertension.

‎ ‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian